RDY Operating Expenses

Dr. Reddy's Laboratories Ltd Common Stock · Operating Expenses

RDY logo

RDY Operating Expenses

Latest reported₹131.73B INR
RDY TTM Operating Expenses · INR (₹6.18B → ₹131.73B)
High-resolution chart · PNG

RDY operating expenses history

Trailing twelve months (TTM) · INR. Each value covers four complete reported quarters.

Dr. Reddy's Laboratories Ltd Common Stock Operating Expenses — Trailing twelve months (TTM) (INR)
Period endingOperating Expenses (INR)
131,728,101,000
128,088,924,000
123,963,000,000
121,727,000,000
121,318,000,000
118,585,000,000
115,493,000,000
110,097,000,000
80,172,220,673
73,670,220,673
47,430,218,757
46,096,218,757
46,071,504,664
37,969,504,664
37,951,319,726
33,704,319,726
33,711,339,864
39,017,339,864
39,004,828,547
43,988,828,547
43,924,557,289
41,450,557,289
57,396,255,460
33,269,340,931
53,376,085,471
48,649,085,471
48,158,085,471
62,969,000,000
58,974,000,000
63,082,000,000
63,622,000,000
65,001,000,000
63,777,000,000
64,389,000,000
63,188,000,000
62,914,000,000
64,524,000,000
64,870,000,000
66,027,000,000
65,910,000,000
64,416,000,000
62,639,000,000
61,536,000,000
60,650,000,000
59,956,000,000
59,076,000,000
58,041,000,000
56,191,000,000
53,778,000,000
50,325,000,000
45,676,000,000
42,757,000,000
40,024,000,000
38,768,000,000
38,111,000,000
36,783,000,000
35,868,000,000
34,014,000,000
32,360,000,000
30,813,000,000
29,112,000,000
27,635,000,000
27,056,000,000
25,727,000,000
25,143,000,000
25,766,000,000
25,454,000,000
25,821,000,000
25,844,015,000
24,897,015,000
24,433,758,012
25,226,969,649
23,509,573,830
21,555,875,579
22,141,615,544
19,480,346,840
19,399,513,457
19,667,401,400
16,515,147,506
14,131,663,663
12,005,843,745
10,358,740,956
10,593,305,280
10,682,107,012
10,900,021,885
10,848,900,415
10,235,739,180
9,978,656,419
9,451,260,775
8,686,574,493
8,008,804,319
7,654,758,127
7,408,002,531
6,873,504,442
6,176,273,636
5,698,226,075
5,055,496,757
4,685,501,594
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.